LAB News and Press, Standard BioTools Inc. From 06/03/25

2025-06-03 13:02:53 ET Summary Standard BioTools, is engaged in product rationalization, cost-cutting and operational efficiency measures in an attempt to turn its business around and transition to profitability. The company’s combination of proteomics, cytometry and microf...

SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation about the rapidly evolving field of proteomics. The s...

2025-05-06 20:08:34 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript Standard BioTools Inc. 2024 Q4 - Results - Earnings Call Presentation Stand...

2025-05-06 20:08:08 ET Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call May 06, 2025, 04:30 PM ET Company Participants John Graziano - VP of IR Michael Egholm - President & CEO Alex Kim - CFO Conference Call Participants K...

2025-05-06 16:09:08 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript Standard BioTools Inc. 2024 Q4 - Results - Earnings Call Presentation Standard BioTools cut to Neutral at KeyBanc on guidance Seeking Alpha’s...

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the first quarter ended March 31, 2025. Recent Highlights: First quarter...

Cyclerion Therapeutics Inc. (CYCN) is expected to report for Q1 2025 Standard BioTools Inc. (LAB) is expected to report $-0.06 for Q1 2025 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2025 CF Bankshares Inc. (CFBK) is expected to report for Q1 2025 Jack Henry & A...

Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from target discovery to clinica...

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that Gerh...

SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report first quarter 2025 financial results on Tuesday, May 6, 2025, after market close. The company will host a conference call and webcast on the same day at 4:...